
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
PHARMACOVIGILLANCE: A WORLD WIDE MASTER KEY. RECOUNTING THE KNOWLEDGE OF THE CURRENT SCIENARIO OF THE PHARMACOVIGILLANCE
Sujal Jaiswal* and Nikita Mahalle
. Abstract Along with therapeutic efficacy, safety is a crucial factor in the everexpanding spectrum and potency of pharmaceuticals and the success of any given drug. India is currently a drug entity's preferred location for clinical studies before commercialization. Pharmacovigilance was developed in response to the rising occurrences of drug-related deaths and the need for accurate detection, reporting, assessment, and comprehension of adverse drug reactions. It is a field of pharmaceutical science with enormous growth potential that is essential to efficient clinical procedures and public health. Effective medication approval regulations are critically needed, as is careful preand post-approved monitoring for unintended effects, particularly in India. This article provided a critical summary of the goals, techniques, and approaches employed in pharmacovigilance. To offer a cuttingedge pharmacovigilance update with a focus on Indian viewpoints and offer pertinent suggestions for enhancing ADR reporting. Keywords: Pharmacogenomics, Pharmacovigilance, Adverse drug events, Adverse drug responses. [Full Text Article] [Download Certificate] |
